These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1314177)

  • 21. Efficacy of atovaquone and sulfadiazine in the treatment of mice infected with Toxoplasma gondii strains isolated in Brazil.
    Alves CF; Vitor RW
    Parasite; 2005 Jun; 12(2):171-7. PubMed ID: 15991831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of A-56268 (TE-031), a new macrolide, against Toxoplasma gondii in mice.
    Chang HR; Rudareanu FC; Pechère JC
    J Antimicrob Chemother; 1988 Sep; 22(3):359-61. PubMed ID: 2972671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative activity of several antibiotics against Toxoplasma gondii in a mouse model].
    Rodríguez-Díaz JC; Martínez-Grueiro MM; Martínez-Fernández AR
    Enferm Infecc Microbiol Clin; 1993 Dec; 11(10):543-6. PubMed ID: 8142504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The evaluation of the efficacy of azithromycin and pyrimethamine used alone or in combination in the treatment of an experimental infection in mice by Toxoplasma gondii].
    Braz LM; Di Pietro AO; Amato Neto V; França FO
    Rev Soc Bras Med Trop; 1999; 32(4):401-3. PubMed ID: 10495670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The timing of sulfadiazine therapy impacts the reactivation of latent Toxoplasma infection in IRF-8-/- mice.
    Jost C; Reiter-Owona I; Liesenfeld O
    Parasitol Res; 2007 Nov; 101(6):1603-9. PubMed ID: 17846793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of trovafloxacin in combination with other drugs for treatment of acute murine toxoplasmosis.
    Khan AA; Slifer T; Araujo FG; Polzer RJ; Remington JS
    Antimicrob Agents Chemother; 1997 May; 41(5):893-7. PubMed ID: 9145840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonionic block copolymers potentiate activities of drugs for treatment of infections with Toxoplasma gondii.
    Araujo FG; Slifer T
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2696-701. PubMed ID: 8593005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of deferoxamine alone and combined with pyrimethamine on acute toxoplasmosis in mice.
    Mahmoud MS
    J Egypt Soc Parasitol; 1999; 29(3):791-803. PubMed ID: 12561919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotherapy in experimental toxoplasmosis: comparison of the efficacy of trimethoprim-sulfur and pyrimethamine-sulfur combinations.
    Seah SK
    J Trop Med Hyg; 1975 Jul; 78(7):150-3. PubMed ID: 1177347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the efficacy of prolonged administration of azithromycin in a murine model of chronic toxoplasmosis.
    Dumas JL; Chang R; Mermillod B; Piguet PF; Comte R; Pechère JC
    J Antimicrob Chemother; 1994 Jul; 34(1):111-8. PubMed ID: 7961197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of trimethoprim and sulfamethoxazole on Toxoplasma gondii in vitro and in vivo.
    Grossman PL; Remington JS
    Am J Trop Med Hyg; 1979 May; 28(3):445-55. PubMed ID: 453442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Azithromycin inhibits vertical transmission of Toxoplasma gondii in Calomys callosus (Rodentia: Cricetidae).
    Costa IN; Angeloni MB; Santana LA; Barbosa BF; Silva MC; Rodrigues AA; Rostkowsa C; Magalhães PM; Pena JD; Silva DA; Mineo JR; Ferro EA
    Placenta; 2009 Oct; 30(10):884-90. PubMed ID: 19703714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis.
    Bosch-Driessen LH; Verbraak FD; Suttorp-Schulten MS; van Ruyven RL; Klok AM; Hoyng CB; Rothova A
    Am J Ophthalmol; 2002 Jul; 134(1):34-40. PubMed ID: 12095805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Buprenorphine does not affect acute murine toxoplasmosis and is recommended as an analgesic in Toxoplasma gondii studies in mice.
    Lindsay DS; Kaur T; Mitchell SM; Goodwin DG; Strobl J; Dubey JP
    J Parasitol; 2005 Dec; 91(6):1488-90. PubMed ID: 16544426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis.
    Araujo FG; Prokocimer P; Lin T; Remington JS
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2454-7. PubMed ID: 1489188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo activity of piritrexim [corrected] against Toxoplasma gondii.
    Araujo FG; Guptill DR; Remington JS
    J Infect Dis; 1987 Nov; 156(5):828-30. PubMed ID: 3484324
    [No Abstract]   [Full Text] [Related]  

  • 37. In vivo synergism of roxithromycin (RU 965) and interferon against Toxoplasma gondii.
    Hofflin JM; Remington JS
    Antimicrob Agents Chemother; 1987 Feb; 31(2):346-8. PubMed ID: 3105452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of azithromycin in a murine toxoplasmosis model, employing a Toxoplasma gondii strain from Turkey.
    Değerli K; Kilimcioğlu AA; Kurt O; Tamay AT; Ozbilgin A
    Acta Trop; 2003 Sep; 88(1):45-50. PubMed ID: 12943976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potent effect of trimetrexate, a lipid-soluble antifolate, on Toxoplasma gondii.
    Kovacs JA; Allegra CJ; Chabner BA; Swan JC; Drake J; Lunde M; Parrillo JE; Masur H
    J Infect Dis; 1987 May; 155(5):1027-32. PubMed ID: 2951446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of epiroprim (Ro11-8958), a new dihydrofolate reductase inhibitor, in the treatment of acute Toxoplasma infection in mice.
    Martinez A; Allegra CJ; Kovacs JA
    Am J Trop Med Hyg; 1996 Mar; 54(3):249-52. PubMed ID: 8600759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.